Messages in brief
Use of unapproved radiopharmaceuticals
Due to the current supply situation of certain radiopharmaceuticals, the Federal Office for Safety in Health Care (BASG)/AGES PharmMed points out…
Doping warnings
On 31.12.2009 the AMG amendment BGBl. I No. 146/2009 came into force, and with it the provision according to which medicinal products containing…
Wafers with anabolic steroids
The OMCL of AGES PharmMed recently tested wafers from illegal production that were fortified with anabolic steroids. The wafers were produced in…
Evaluation grid for the delimitation of pharmacy operations
§ Section 1 of the Pharmaceutical Operations Ordinance 2009 (AMBO 2009) circumscribes the scope of the operations ordinance. New regulations concern…
Data input via PharmaIS web portal
Due to technical changes and conversions, there were more error messages in the PharmaIS web portal from 27.11.2009 to 23.12.2009.
If you have…
Vikela ("morning after pill") over the counter
As of Dec. 17, 2009, Vikela 1.5 mg tablet (levonorgestel) was made available without a prescription to women of all ages by a decision proposed by the…
Approval & Lifecycle Management: Electronic Submission
New §24/§25 AMG application form
As of 10.12.2009, a new, slightly modified application form is available for purely national variation applications. These changes are not related…
Pharmacovigilance: PSUR Worksharing
